6.
Brown R, Kabani K, Favaloro J, Yang S, Ho P, Gibson J
. CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood. 2012; 120(10):2055-63.
DOI: 10.1182/blood-2012-03-416792.
View
7.
Castelli E, Mendes-Junior C, Deghaide N, de Albuquerque R, Muniz Y, Simoes R
. The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun. 2009; 11(2):134-41.
DOI: 10.1038/gene.2009.74.
View
8.
Chen D, Wang P, Hour A, Lin W, Hsu F, Wang W
. The association between genetic variants at 3'-UTR and 5'-URR of HLA-G gene and the clinical outcomes of patients with leukemia receiving hematopoietic stem cell transplantation. Front Immunol. 2023; 14:1093514.
PMC: 9995383.
DOI: 10.3389/fimmu.2023.1093514.
View
9.
Contini P, Murdaca G, Puppo F, Negrini S
. HLA-G Expressing Immune Cells in Immune Mediated Diseases. Front Immunol. 2020; 11:1613.
PMC: 7484697.
DOI: 10.3389/fimmu.2020.01613.
View
10.
Cordeiro J, Fernandes T, Toro D, da Silva-Neto P, Pimentel V, Perez M
. The Severity of COVID-19 Affects the Plasma Soluble Levels of the Immune Checkpoint HLA-G Molecule. Int J Mol Sci. 2022; 23(17).
PMC: 9456149.
DOI: 10.3390/ijms23179736.
View
11.
da Silva G, Vianna P, Veit T, Crovella S, Catamo E, Cordero E
. Influence of HLA-G polymorphisms in human immunodeficiency virus infection and hepatitis C virus co-infection in Brazilian and Italian individuals. Infect Genet Evol. 2014; 21:418-23.
DOI: 10.1016/j.meegid.2013.12.013.
View
12.
de Almeida B, Costa Netto Muniz Y, Prompt A, Castelli E, Mendes-Junior C, Donadi E
. Genetic association between HLA-G 14-bp polymorphism and diseases: A systematic review and meta-analysis. Hum Immunol. 2018; 79(10):724-735.
DOI: 10.1016/j.humimm.2018.08.003.
View
13.
Donadi E, Castelli E, Arnaiz-Villena A, Roger M, Rey D, Moreau P
. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci. 2010; 68(3):369-95.
PMC: 3021195.
DOI: 10.1007/s00018-010-0580-7.
View
14.
El Baba R, Herbein G
. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation. Front Immunol. 2021; 12:730765.
PMC: 8456041.
DOI: 10.3389/fimmu.2021.730765.
View
15.
Gan J, Di X, Yan Z, Gao Y, Xu H
. 3'UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis. Front Immunol. 2023; 13:1076040.
PMC: 9810980.
DOI: 10.3389/fimmu.2022.1076040.
View
16.
Gebhard C, Regitz-Zagrosek V, Neuhauser H, Morgan R, Klein S
. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020; 11(1):29.
PMC: 7247289.
DOI: 10.1186/s13293-020-00304-9.
View
17.
Jasinski-Bergner S, Mandelboim O, Seliger B
. Molecular mechanisms of human herpes viruses inferring with host immune surveillance. J Immunother Cancer. 2020; 8(2).
PMC: 7333871.
DOI: 10.1136/jitc-2020-000841.
View
18.
Jasinski-Bergner S, Eckstein M, Taubert H, Wach S, Fiebig C, Strick R
. The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors. Front Immunol. 2022; 13:811200.
PMC: 8855320.
DOI: 10.3389/fimmu.2022.811200.
View
20.
Jasinski-Bergner S, Schmiedel D, Mandelboim O, Seliger B
. Role of HLA-G in Viral Infections. Front Immunol. 2022; 13:826074.
PMC: 8882596.
DOI: 10.3389/fimmu.2022.826074.
View
21.
Krijgsman D, Roelands J, Hendrickx W, Bedognetti D, Kuppen P
. HLA-G: A New Immune Checkpoint in Cancer?. Int J Mol Sci. 2020; 21(12).
PMC: 7350262.
DOI: 10.3390/ijms21124528.
View